This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Jefferies analyst Janardan Menon downgraded the rating for ASML Holding N.V. ASML from Buy to Hold. ASML shares closed at $815.24 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Alec Brondolo downgraded The Trade Desk, Inc. TTD from Overweight to Equal-Weight and lowered the price target from $74 to $68. Trade Desk shares closed at $69.80 on Wednesday. See how other analysts view this stock.
  • JMP Securities analyst Jordan Bender downgraded MGM Resorts International MGM from Market Outperform to Market Perform. MGM Resorts shares closed at $33.88 on Wednesday. See how other analysts view this stock.
  • Mizuho analyst Graig Suvannavejh downgraded Adaptimmune Therapeutics plc ADAP from Outperform to Neutral and cut the price target from $1.5 to $0.5. Adaptimmune Therapeutics shares closed at $0.2530 on Wednesday. See how other analysts view this stock.
  • UBS analyst Eliana Merle downgraded CureVac N.V. CVAC from Buy to Neutral and lowered the price target from $12 to $5.5. CureVac shares closed at $5.44 on Wednesday. See how other analysts view this stock.

Considering buying TTD stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Loading...
Loading...
ADAP Logo
ADAPAdaptimmune Therapeutics PLC
$0.2337-7.63%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
4.63
Growth
Not Available
Quality
Not Available
Value
35.53
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...